- Home
- ALRM vs MRUS Comparison
ALRM vs MRUS Comparison
Compare ALRM & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALRM
- MRUS
- Stock Information
- Founded
- ALRM 2000
- MRUS 2003
- Country
- ALRM United States
- MRUS Netherlands
- Employees
- ALRM N/A
- MRUS N/A
- Industry
- ALRM Computer Software: Prepackaged Software
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- ALRM Technology
- MRUS Health Care
- Exchange
- ALRM Nasdaq
- MRUS Nasdaq
- Market Cap
- ALRM 2.8B
- MRUS 2.7B
- IPO Year
- ALRM 2015
- MRUS 2016
- Fundamental
- Price
- ALRM $57.40
- MRUS $56.07
- Analyst Decision
- ALRM Buy
- MRUS Strong Buy
- Analyst Count
- ALRM 6
- MRUS 15
- Target Price
- ALRM $64.33
- MRUS $88.87
- AVG Volume (30 Days)
- ALRM 343.2K
- MRUS 1.6M
- Earning Date
- ALRM 05-08-2025
- MRUS 05-07-2025
- Dividend Yield
- ALRM N/A
- MRUS N/A
- EPS Growth
- ALRM 39.57
- MRUS N/A
- EPS
- ALRM 2.36
- MRUS N/A
- Revenue
- ALRM $955,366,000.00
- MRUS $54,732,000.00
- Revenue This Year
- ALRM $6.93
- MRUS $39.00
- Revenue Next Year
- ALRM $4.18
- MRUS $7.48
- P/E Ratio
- ALRM $24.29
- MRUS N/A
- Revenue Growth
- ALRM 6.71
- MRUS 42.77
- 52 Week Low
- ALRM $48.23
- MRUS $33.19
- 52 Week High
- ALRM $71.98
- MRUS $61.28
- Technical
- Relative Strength Index (RSI)
- ALRM 53.98
- MRUS 66.86
- Support Level
- ALRM $56.03
- MRUS $49.46
- Resistance Level
- ALRM $58.06
- MRUS $56.74
- Average True Range (ATR)
- ALRM 1.31
- MRUS 3.37
- MACD
- ALRM -0.17
- MRUS 1.57
- Stochastic Oscillator
- ALRM 28.96
- MRUS 91.31
About ALRM Alarm.com Holdings Inc.
Alarm.com Holdings Inc has a cloud-based platform that offers an expansive suite of IoT solutions addressing world-wide opportunities in the residential, multi-family, small business and enterprise commercial markets. It has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected devices.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.